$23.46
4.71% today
Nasdaq, Feb 28, 05:18 pm CET
ISIN
US86881A1007
Symbol
SGRY

Surgery Partners, Inc. Stock price

$24.62
+3.37 15.86% 1M
-7.87 24.22% 6M
+3.45 16.30% YTD
-7.22 22.68% 1Y
-27.65 52.90% 3Y
+7.52 43.98% 5Y
+6.51 35.95% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.43 1.72%
ISIN
US86881A1007
Symbol
SGRY
Sector

Key metrics

Market capitalization $3.13b
Enterprise Value $8.08b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 49.44
EV/Sales (TTM) EV/Sales 2.71
P/S ratio (TTM) P/S ratio 1.05
P/B ratio (TTM) P/B ratio 1.65
Revenue growth (TTM) Revenue growth 9.96%
Revenue (TTM) Revenue $2.99b
EBIT (operating result TTM) EBIT $432.20m
Free Cash Flow (TTM) Free Cash Flow $163.40m
Cash position $221.80m
EPS (TTM) EPS $-0.48
P/E forward negative
P/S forward 1.02
EV/Sales forward 2.62
Short interest 16.37%
Show more

Is Surgery Partners, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Surgery Partners, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Surgery Partners, Inc. forecast:

9x Buy
75%
3x Hold
25%

Analyst Opinions

12 Analysts have issued a Surgery Partners, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Surgery Partners, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,985 2,985
10% 10%
100%
- Direct Costs 2,430 2,430
11% 11%
81%
556 556
7% 7%
19%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
582 582
9% 9%
19%
- Depreciation and Amortization 150 150
5% 5%
5%
EBIT (Operating Income) EBIT 432 432
10% 10%
14%
Net Profit -61 -61
77% 77%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about Surgery Partners, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Surgery Partners, Inc. Stock News

Positive
Seeking Alpha
one day ago
REITs have surged in value. But opportunities still remain for income-oriented investors. I present two REITs to buy today.
Neutral
GlobeNewsWire
10 days ago
BRENTWOOD, Tenn., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2024 results before the market opens on Monday, March 3, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time).
Positive
Seeking Alpha
28 days ago
As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. The value of private equity investment in Japan jumped nearly 41% over the prior-year total in 2024, far outpacing the 25% year-over-year gain in global private equity deal value, according to S&P Global Market Intelligence data.
More Surgery Partners, Inc. News

Company Profile

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Head office United States
CEO J. Evans
Employees 13,500
Founded 2004
Website www.surgerypartners.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today